LXEO vs ROK · $147.7M cap vs P/E 48, rev $8.34B
Lexeo Therapeutics, Inc. Common Stock (LXEO) versus Rockwell Automation Inc (ROK) — a side-by-side from cached financials, not a winner call.
Lexeo Therapeutics, Inc. Common Stock (LXEO) is a biotechnology company listed on US.
Rockwell Automation Inc (ROK) is a specialty industrial machinery company listed on NYSE.
LXEO does not have a complete income-statement cache yet.
Latest reported ROK revenue for 2025-09-30 was $8.34B. Net income was $749.0M. ROK currently screens at market cap $51.04B and trailing P/E 47.5.
LXEO currently screens at market cap $147.7M. ROK currently screens at market cap $51.04B and trailing P/E 47.5.
Not investment advice. Open the LXEO and ROK stock pages for the full models.
Not investment advice.